Wang J S, Aspenberg P
Department of Orthopedics, Lund University Hospital, Sweden.
Acta Orthop Scand. 1994 Feb;65(1):27-31. doi: 10.3109/17453679408993713.
We found increased penetration of new bone into a frozen bone allograft which had been pretreated with basic fibroblast growth factor (bFGF). Pairs of grafts were placed in newly designed titanium bone chambers implanted bilaterally in rat tibiae. The ingrowing bone can enter the cylindrical interior of the chamber only at one end. It then penetrates the graft inside the chamber but, due to the length of the cylinder, it never reaches the other end. The distance which the ingrown bone has reached into the graft can then be measured on histological slides. With bFGF there was a 51 percent increase in the bone penetration distance at 6 weeks in this model. It also appeared that further penetration had almost ceased in the controls, whereas in the bFGF-treated specimens, membranous ossification was still going on.
我们发现,在用碱性成纤维细胞生长因子(bFGF)预处理过的冷冻同种异体骨移植物中,新骨的渗透有所增加。将成对的移植物置于新设计的钛制骨腔中,双侧植入大鼠胫骨。长入的骨只能从一端进入腔室的圆柱形内部。然后它穿透腔内的移植物,但由于圆柱体的长度,它永远无法到达另一端。然后可以在组织学切片上测量长入的骨进入移植物的距离。在该模型中,使用bFGF后,6周时骨渗透距离增加了51%。还发现,在对照组中,进一步的渗透几乎已经停止,而在bFGF处理的标本中,膜内成骨仍在继续。